🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
This randomized phase III trial studies carboplatin given together with pac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-10-12
Trial ID
NCT01081262
This phase II trial studies the side effects of bevacizumab and anetumab ra...
Status
Active Not Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Start Date
2018-10-12
Trial ID
NCT03587311
Treatments Being Tested
AMAZE-lung is a multicenter single-arm phase II trial. The protocol treatme...
Status
Active Not Recruiting
Location
Chu Angers
Start Date
2023-03-27
Trial ID
NCT05601973
Treatments Being Tested
This randomized phase II trial studies how well cediranib maleate and olapa...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2017-12-07
Trial ID
NCT02974621
Treatments Being Tested
This randomized phase III trial studies octreotide acetate and recombinant ...
Status
Active Not Recruiting
Location
Providence Hospital
Start Date
2007-12-01
Trial ID
NCT00569127
Treatments Being Tested
This phase II trial studies how well atezolizumab and bevacizumab work in t...
Status
Completed
Location
Los Angeles County-USC Medical Center
Start Date
2017-03-10
Trial ID
NCT02921269
Treatments Being Tested
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-10-19
Trial ID
NCT05863195
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206
This phase III trial compares the effect of olaparib for one year versus tw...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-03-12
Trial ID
NCT06580314
Treatments Being Tested